|
FPGT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.50979270488961E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02311517433418E-12 |
| Normal-vs-Stage2 |
2.643800E-04 |
| Normal-vs-Stage3 |
2.90599999619445E-08 |
| Normal-vs-Stage4 |
3.856200E-02 |
| Stage1-vs-Stage2 |
4.133600E-01 |
| Stage1-vs-Stage3 |
8.864000E-01 |
| Stage1-vs-Stage4 |
2.939000E-01 |
| Stage2-vs-Stage3 |
4.174000E-01 |
| Stage2-vs-Stage4 |
7.250200E-01 |
| Stage3-vs-Stage4 |
3.023600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.87141446573014E-12 |
| Normal-vs-AfricanAmerican |
4.6931003527817E-10 |
| Normal-vs-Asian |
1.836240E-03 |
| Caucasian-vs-AfricanAmerican |
8.276000E-01 |
| Caucasian-vs-Asian |
7.825200E-01 |
| AfricanAmerican-vs-Asian |
8.360200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98485672342485E-12 |
| Normal-vs-Female |
2.16300000022152E-07 |
| Male-vs-Female |
2.641700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.04239999965117E-08 |
| Normal-vs-Extreme_Weight |
1.64257496493292E-12 |
| Normal-vs-Obese |
1.93979998730498E-09 |
| Normal-vs-Extreme_Obese |
1.008300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.510400E-01 |
| Normal_Weight-vs-Obese |
7.834200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.715600E-01 |
| Extreme_Weight-vs-Obese |
1.232830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.153000E-01 |
| Obese-vs-Extreme_Obese |
7.858400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.00449999990349E-07 |
| Normal-vs-Age(41-60Yrs) |
1.02989949901655E-10 |
| Normal-vs-Age(61-80Yrs) |
1.47726275656623E-12 |
| Normal-vs-Age(81-100Yrs) |
5.31489999788803E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.194600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.085400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.966800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.050400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.622620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.743800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62569957495862E-12 |
| Normal-VS-Type2 PRCC |
3.44619999981255E-07 |
| Normal-VS-KIRP CIMP |
1.13140000002065E-06 |
| Normal-VS-Unclassified PRCC |
6.11579999976186E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.739700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.500000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.646500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.060200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.578000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.813600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37109998302287E-10 |
| Normal-vs-N1 |
1.717150E-03 |
| Normal-vs-N2 |
6.204500E-04 |
| N0-vs-N1 |
2.778000E-01 |
| N0-vs-N2 |
7.249200E-01 |
| N1-vs-N2 |
4.826200E-01 |
|
|
